Antiviral for Systemic Use of Hcv - Elbasvir_Grazoprevir Iii.

CzechTenders notice for Antiviral for Systemic Use of Hcv - Elbasvir_Grazoprevir Iii.. The reference ID of the tender is 88301179 and it is closing on 02 Oct 2023.

100% Secure Payments

Tender Details

  • Country: Czech Republic
  • Summary: Antiviral for Systemic Use of Hcv - Elbasvir_Grazoprevir Iii.
  • CZT Ref No: 88301179
  • Deadline: 02 Oct 2023
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: 13535703
  • Notice Type: Tender
  • Document Ref. No.: 531620-2023
  • Purchaser's Detail :
    Address : VideĊˆska 1958/9
    Town : Prague
    NUTS-Code : CZ010 - Capital Prague
    Postal Code : 14000
    Contact Point : Ing. Klara Sovjakova
    Phone: 420 261365598

  • Description :
  • The subject of the public contract is the regular supply of medicinal products containing the active substances elbasvir and grazoprevir (ATC group J05AP54) for the treatment of patients in approved indications according to the SPC valid on the date of submission of the offer.
    Doc Title: Antivirals for systemic use
    Contract Type: Supplies
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CzechTenders Features

CzechTenders Features

Fresh and verified Tenders from Czech. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Czech in your email inbox.

  Chat with us